Press Releases

News Brief

Samsung Biologics to attend series of global conferences to showcase enhanced capabilities

 

Samsung Biologics will be attending CPHI Worldwide in Milan between October 8-10 for a series of meetings with existing and potential clients on how the company can support their pipelines.


At booth #5B33, the company will highlight its enhanced CDMO capabilities and service offerings regarding various modalities, including Multispecific antibodies, complex molecules, ADC, and mRNA.


Samsung Biologics will also share developments regarding the construction of Plant 5, which will be operational by April 2025. The company is poised to offer a total capacity of 784 kL when complete. Samsung Biologics is also building a dedicated ADC facility that will be complete by the year’s end.


During October 9-11, the company will attend BioJapan in Yokohama. Samsung Biologics plans to hold networking sessions with global clients on collaboration opportunities to support their development goals. Visit the partnering zone – Room #PTR-5 to meet with our team.



 

Samsung Biologics will be attending CPHI Worldwide in Milan between October 8-10 for a series of meetings with existing and potential clients on how the company can support their pipelines.


At booth #5B33, the company will highlight its enhanced CDMO capabilities and service offerings regarding various modalities, including Multispecific antibodies, complex molecules, ADC, and mRNA.


Samsung Biologics will also share developments regarding the construction of Plant 5, which will be operational by April 2025. The company is poised to offer a total capacity of 784 kL when complete. Samsung Biologics is also building a dedicated ADC facility that will be complete by the year’s end.


During October 9-11, the company will attend BioJapan in Yokohama. Samsung Biologics plans to hold networking sessions with global clients on collaboration opportunities to support their development goals. Visit the partnering zone – Room #PTR-5 to meet with our team.


SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION